Of the 250,000 new cases of breast cancer detected annually, intra-operative radiation therapy (IORT) vendor iCAD believes its Xoft Axxent eBx system may be able to treat as many as 110,000, sparing many women the months-long, post-surgical treatment associated with external beam radiation therapy (EBRT).